科倫博泰招股進行中 創新藥浪潮下何以大放異彩？
Jun 30, 2023 10:32 HKT | |
|
Soligenix, Inc. CEO is Featured in an Interview with SmallCaps Daily
Jun 29, 2023 20:00 HKT |  |
|
NanoViricides Announces that Clinical Trials of Its Broad-Spectrum Antiviral Drug NV-CoV-2 Have Begun
Jun 29, 2023 18:45 HKT |  |
|
NanoViricides Announces that Clinical Trials of Its Broad-Spectrum Antiviral Drug NV-CoV-2 Have Begun
Jun 29, 2023 18:45 HKT | |
|
BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development
Jun 29, 2023 17:00 HKT |  |
|
四环医药：旗下轩竹生物创新药品安奈拉唑钠肠溶片获国家药监局批准上市
Jun 27, 2023 13:02 HKT |  |
|
四環醫藥：旗下軒竹生物創新藥品安奈拉唑鈉腸溶片獲國家藥監局批准上市
Jun 27, 2023 13:01 HKT | |
|
Xuanzhu Biopharm, a subsidiary of Sihuan Pharmaceutical, Its Innovative Drug Anaprozole Sodium Enteric-coated Tablets Obtains Drug Registration Approval From NMPA
Jun 27, 2023 13:00 HKT | |
|
Prenetics与全球知名科学家卢煜明教授宣布成立2亿美元合资企业“Insighta” 推出突破性多种癌症早期筛查检测
Jun 26, 2023 09:39 HKT | |
|
Prenetics與全球知名科學家盧煜明教授宣布成立2億美元合資企業「Insighta」推出突破性多種癌症早期篩查檢測
Jun 26, 2023 09:38 HKT | |
|
Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture "Insighta" for Breakthrough Multi-Cancer Early Detection Screening
Jun 26, 2023 09:37 HKT | |
|
OKRA.ai, an Envision Pharma Group Company, Appoints Dr. Yahya Anvar to Senior Leadership Position
Jun 15, 2023 19:00 HKT |  |
|
With an Eye on the Future, Biolog Launches Odin
Jun 15, 2023 17:09 HKT | |
|
沛嘉医疗TaurusTrio经导管主动脉瓣系统获批NMPA创新医疗器械绿色通道
Jun 14, 2023 10:51 HKT | |
|
沛嘉醫療TaurusTrio經導管主動脈瓣系統獲批NMPA創新醫療器械綠色通道
Jun 14, 2023 10:50 HKT | |
|
Proventus Bioscience Breaks Ground on Its New Production Facility and Expansion of Its Laboratories and Fermentation Plant
Jun 13, 2023 22:00 HKT |  |
|
中国抗体SM17再增一项适应症研究申请 针对治疗特应性皮炎（AD）的新药研究申请获国家药监局药品审评中心受理
Jun 12, 2023 20:45 HKT |  |
|
中國抗體SM17再增一項適應症研究申請 針對治療特應性皮炎（AD）的新藥研究申請獲國家藥監局藥品審評中心受理
Jun 12, 2023 20:44 HKT | |
|
SinoMab Submits another IND Application for SM17 for the Treatment of Atopic Dermatitis, Which was Accepted by NMPA CDE
Jun 12, 2023 20:43 HKT | |
|
Xuanzhu Biopharm, a subsidiary of Sihuan Pharmaceutical, progresses at full speed in innovative research and development, Presents major research results of birociclib, the start product, at the international stage in ASCO
Jun 08, 2023 21:18 HKT | |
|